Dec 4 (Reuters) - Amplia Therapeutics Ltd (ATX) :
- APPROVAL FROM KOREAN REGULATOR TO INITIATE PHASE 2 ACCENT PANCREATIC CANCER TRIAL IN KOREA
News: ATX Amplia Therapeutics Says Approval From Korean Regulator
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.01M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21854 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 77798 | 1 |
View Market Depth
| Last trade - 10.10am 06/06/2024 (20 minute delay) ? |
| ATX (ASX) Chart |
Day chart unavailable